This month we interview Shijia Tang, principal scientist at Genentech, South San Francisco, CA, USA, about her innovative research focusing on the analysis of polymers and nanomaterials used in pharmaceutical analysis. Shijia decribes the benefits of an innovative in-line mixing modulation method for 2D-LC she developed for polymer and oligonucleotide analysis. The advantages of SEC–MALS to explore aggregation mechanisms for therapeutic constrained
peptides and mRNA-lipid nanoparticles and their aggregates are also discussed.
Shijia Teng is principal scientist at Genentech in South Francisco, CA, USA. Her research focuses on the analysis of polymers and nanomaterials used in pharmaceutical analysis. She has emerged as a key contributor in quantifying polymers in diverse pharmaceutical products, including amorphous solid dispersions and supramolecular hydrogels. Her research has enhanced the comprehension of polymer release kinetics and mechanisms in these intricate and emerging pharmaceutical formulations. She is an author of 15 publications including Journal of American Chemical Society, Analytical Chemistry, Journal of Chromatography A, and Molecular Pharmaceutics.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.